Very High-Power Short-Duration (HPSD) Ablation for Pulmonary Vein Isolation: Short and Long-Term Outcome Data
Authors:
- Sebastian SeidlSSSebastian Seidl
- Tanja MüllederTMTanja Mülleder
- Josef KaiblingerJKJosef Kaiblinger
- Stefan SieghartsleitnerSSStefan Sieghartsleitner
- Jasmina Alibegovic-ZaborskyJAJasmina Alibegovic-Zaborsky
- Elisabeth SigmundESElisabeth Sigmund
- Michael DerndorferMDMichael Derndorfer
- Georg KolliasGKGeorg Kollias
- Helmut PürerfellnerHPHelmut Pürerfellner
- Martin MartinekMMMartin Martinek
Open Access
- 18 August 2022
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (8) , 278
Abstract
Background: Circumferential pulmonary vein isolation (PVI) using radiofrequency ablation (RFA) is a standard of care intervention for patients with symptomatic atrial fibrillation (AF). During follow-up, a substantial number of patients need a redo procedure due to reconnections on the basis of insufficient non-transmural ablation lesions. High-power short-duration ablation (HPSD) is expected to create efficient lesions while causing fewer complications than in conventional RFA settings. The aim of this study was to compare one-year outcome data of very HPSD (90 Watt, 4 s) to a strategy using 50 Watt HPSD ablation guided by the CLOSE protocol using the Ablation Index (AI), an arbitrary unit composed of power, contact force and ablation time. Methods: We retrospectively analyzed short and long-term (median follow-up 23.2 ± 9.9 months) outcome data from 52 patients that were scheduled for first-do-symptomatic PVI. A very HPSD ablation protocol with 90 Watt and a 4 s duration cut-off was compared to an HPSD CLOSE approach (50 Watts; AI 550 at the anterior LA wall; AI 400 at the posterior LA wall, the roof and the floor) in terms of freedom from AF recurrence in a long-term electrocardiogram (ECG) over a five days surveillance period. To gain an impression of the subjective sense of wellbeing, the Atrial Fibrillation Effects on QualiTy-of-Life (AFEQT) score was recorded. Results: Overall freedom from AF was found in 81% (90 W 4 s) vs. 87.5% (50 W), (p = 0.52). There were 3 AF recurrences during the blanking period (90 W 4 s) vs. 1 (50 W). Within each population, one patient was scheduled for a redo-PVI-procedure. The AFEQT score was in favor of the 90 Watt 4 s approach (86.1 vs. 77.5; p = 0.37). Conclusion: Within our relatively small studied population, we found hints that in addition to shortening ablation times and radiation exposure without significantly increasing the rate of relevant intraprocedural complications, very high power short-duration ablation (90 W 4 s) provides comparable efficacy rates after one year.Keywords
This publication has 12 references indexed in Scilit:
- 90 vs 50-Watt Radiofrequency Applications for Pulmonary Vein Isolation: Experimental and Clinical FindingsCirculation: Arrhythmia and Electrophysiology, 2022
- Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG studyJournal of Interventional Cardiac Electrophysiology, 2022
- Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablationInternational Journal of Cardiology, 2021
- Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled LesionsJACC: Clinical Electrophysiology, 2019
- Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013Heart, 2019
- High‐power and short‐duration ablation for pulmonary vein isolation: Safety, efficacy, and long‐term durabilityJournal of Cardiovascular Electrophysiology, 2018
- High-Power and Short-Duration Ablation for Pulmonary Vein IsolationJACC: Clinical Electrophysiology, 2018
- Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocolEP Europace, 2018
- The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modificationEP Europace, 2014
- Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2011